首页   >  
Neuro Signaling Pathway
  • GPCR/G Protein
  >  
CGRP Receptor

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

CGRP Receptor

结构式 货号 产品名称 CAS号
Ubrogepant 结构式
BCP24753 乌布吉泮 1374248-77-7
Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.
Vazegepant hydrochloride 结构式
BCP46799 Vazegepant hydrochloride 1414976-20-7
Vazegepant hydrochloride is a highly affinity CGRP receptor antagonist (hCGRP Ki= 0.023 nM). Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Vazegepant 结构式
BCP46647 Vazegepant 1337918-83-8
Vazegepant, also known as Zavegepant, BHV-3500 and BMS 742413, is a highly potent, selective and structurally unique small molecule CGRP receptor antagonist. Vazegepant is the first and only CGRP receptor antagonist for intranasal administration currently in development for the acute treatment of migraine.
Rimegepant sulfate hydrate 结构式
BCP42168 硫酸利美戈潘 1374024-48-2
Rimegepant is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines.
BIBN 4096BS 结构式
BCP29403 BIBN 4096BS 204697-65-4
BIBN 4096BS is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP.
Rimegepant 结构式
BCP28575 瑞美吉泮 1289023-67-1
Rimegepant is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
MK-8031 结构式
BCP29018 MK-8031 1374248-81-3
MK-8031, also known as Atogepant, is a calcitonin gene-related peptide receptor antagonist.
MK-3207 HCl 结构式
BCP27622 MK 3207 盐酸盐 957116-20-0
MK-3207 (Hydrochloride) is a potent and orally bioavailable CGRP receptor antagonist with IC50 of 0.12 nM and Ki of 0.024 nM, and is highly selective versus human AM1, AM2, CTR, and AMY3.
Telcagepant 结构式
BCP07257 Telcagepant 781649-09-0
MK-0974 is a highly potent, selective, and orally bioavailable CGRP receptor antagonist, which may be valuable in the acute treatment of migraine.
MK 3207 结构式
BCP02225 MK 3207 957118-49-9
MK-3207 is a potent and orally bioavailable CGRP receptor antagonist. In common with other CGRP receptor antagonists, MK-3207 displays lower affinity for human CGRP receptors from other species, including canine and rodent.
2853530910